This is an auto-generated stub page built from atlas entry frontmatter. A richer
hand-crafted page is planned. See the
atlas source
for the full entry including detailed body sections.
wilms-tumor
Wilms Tumor
Wilms tumor (nephroblastoma) is the most common pediatric renal malignancy; peak age 3-4 years; favorable histology ~90% with 4-year OS >95%; anaplastic ~10% with TP53 mutations; WT1/CTNNB1/WTX/DROSHA drivers; actinomycin D+vincristine±doxorubicin backbone.
Entry Metadata
| Field | Value |
|---|---|
| ID | wilms-tumor |
| Name | Wilms Tumor |
| Status | draft |
| Last reviewed | 2026-06-06 |
| Atlas | 01-human |
| Scale | 07-system |
Cross-Atlas Connections
Sources
- Dome JS, Graf N, Geller JI, et al. Advances in Wilms tumor treatment and biology: progress through international collaboration. J Clin Oncol. 2015;33(27):2999-3007. · PubMed 26261251
- Dix DB, Bhatt SM, Geller JI, et al. Treatment of Stage IV favorable histology Wilms tumor with incomplete lung metastasis response after chemotherapy: a report from Children's Oncology Group Study AREN0533. J Clin Oncol. 2018;36(16):1564-1570. · PubMed 29584550